Solvay Pharmaceuticals SA SA
Solvay Pharmaceuticals SA reported total assets of €28.1m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of Solvay Pharmaceuticals SA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -37 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Solvay Pharmaceuticals SA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jun 2022
Solvay Pharmaceuticals SA's financial analysis
- Solvency0.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Solvay Pharmaceuticals SA
Solvay Pharmaceuticals SA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.542.370
- VAT number
- BE0877542370
- Peppol
- Registered · 0208:0877542370 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Nov 2005
- Registered office
- 1120 Brussels
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Activities of head offices (NACE 70100)
Solvay Pharmaceuticals SA (SA) has been based in Brussels since 2005, active in: activities of head offices. For 2025, it reports a net profit of 904,977 € and equity of 133,309 €; its revenue is not published. Its solvency stands at 0.5%, below the median of its sector (46.0%).
Companies similar to Solvay Pharmaceuticals SA
Companies in the same business, of comparable size and area, outside its group.
- Antwerpse Ontwikkelings- en Investeringsmaatschappij Activities of holding companies Ixelles · balance sheet €29.9m
- CNBB Equity Partners I Activities of holding companies Antwerp · balance sheet €27.5m
- Nestor Europe Other business support service activities n.e.c. Sint-Martens-Latem · balance sheet €30.5m
- E2A Partners Activities of holding companies Schaerbeek · balance sheet €34.1m
- Emandendi Investment Activities of holding companies Schilde · balance sheet €17.8m
- DPA 056 Activities of holding companies Brussels · balance sheet €22.4m
- Magnus II Activities of holding companies Antwerp · balance sheet €67.9m
- Belsorg Activities of holding companies Saint-Gilles · balance sheet €65.8m
Frequently asked questions about Solvay Pharmaceuticals SA
What is the revenue of Solvay Pharmaceuticals SA?
Solvay Pharmaceuticals SA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Solvay Pharmaceuticals SA?
In Belgium, the VAT number is the company number prefixed with BE: BE0877542370 for Solvay Pharmaceuticals SA, if the company is VAT-registered. Its company number (CBE) is 0877.542.370.
Where is the registered office of Solvay Pharmaceuticals SA?
According to the CBE register, the registered office of Solvay Pharmaceuticals SA is in 1120 Brussels.
What is the equity of Solvay Pharmaceuticals SA?
At the close of the 2025 financial year, the equity of Solvay Pharmaceuticals SA amounts to 133,309 €, a solvency of 0.5% of total assets.
Who manages Solvay Pharmaceuticals SA?
The register lists 3 active mandates at Solvay Pharmaceuticals SA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Solvay Pharmaceuticals SA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →